| Mrs Sheila Renee Seal, MS, CCC-SLP | |
|
203 Pine Hill Ct, Nixa, MO 65714-6712 | |
| (417) 724-0996 | |
| Not Available |
| Full Name | Mrs Sheila Renee Seal |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 203 Pine Hill Ct, Nixa, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215228986 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2002000632 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sheila Renee Seal, MS, CCC-SLP 203 Pine Hill Ct, Nixa, MO 65714-6712 Ph: () - | Mrs Sheila Renee Seal, MS, CCC-SLP 203 Pine Hill Ct, Nixa, MO 65714-6712 Ph: (417) 724-0996 |
News Archive
Relievant Medsystems, Inc. today announced the company has received Food and Drug Administration approval of an Investigational Device Exemption to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept System for treatment of chronic low back pain.
Newt Gingrich's super PAC is out with an ad launching a new attack on Mitt Romney's health care record in Massachusetts -; and reviving stories about his plan's influence on "Obamacare."
The Wistar Institute is pleased to announce that the National Institutes of Health has awarded a nearly $23 million Martin Delaney Collaboratories for HIV Cure Research grant to the BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, a consortium of top HIV researchers led by co-principal investigators Luis J. Montaner, D.V.M., D.Phil., director of the HIV-1 Immunopathogenesis Laboratory at The Wistar Institute Vaccine Center, and James L. Riley, Ph.D., research associate professor at the Perelman School of Medicine at the University of Pennsylvania.
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.
› Verified 2 days ago
Juliette Wutke, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 North St, Annex B, Nixa, MO 65714 Phone: 417-724-4040 Fax: 417-724-4039 | |
Amy Vangorden, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 North St, Annex B, Nixa, MO 65714 Phone: 417-724-4040 Fax: 417-724-4039 | |
Cece Lewis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Gregg Rd, Nixa, MO 65714 Phone: 417-875-5650 | |
Pamela Engle, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1887 N State Highway Cc, Nixa, MO 65714 Phone: 417-725-5774 Fax: 417-725-5915 | |
Nicole Blanchard, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1801 Quail Ln, Nixa, MO 65714 Phone: 816-390-2110 | |
Sharon Bennett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 512 S Pepperhill Dr, Nixa, MO 65714 Phone: 417-569-2890 | |
Kathy Turpin, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 826 W Meadowview Dr, Nixa, MO 65714 Phone: 417-268-5413 |